Symbol List Views
Stock Details
CHARTS
COMPANY NEWS
STOCK ANALYSIS
FUNDAMENTALS
HOLDINGS
Edit Symbol List
Symbol Lookup
PTIE: Stock Quote & Summary Data
0.85%
| Last Sale | |
| Change Net / % |
|
| Best Bid / Ask | |
| 1y Target Est: | $ 5.00 |
| Today's High / Low | / |
| Share Volume | |
| 50 Day Avg. Daily Volume | 247,100 |
| Previous Close | $ 4.71 |
| 52 Wk High / Low | $ 9.32 / $ 3.20 |
| Shares Outstanding | 42,188,000 |
| Market Value | $ 200,393,000 |
| P/E Ratio | NE |
| Forward P/E (1yr) | NE |
| Earnings Per Share | $ -0.10 |
| Annualized Dividend | N/A |
| Ex Dividend Date | N/A |
| Dividend Payment Date | N/A |
| Current Yield | N/A |
| Beta | 1 |
| NASDAQ Official Open Price: | $ 4.70 |
| Date of NASDAQ Official Open Price: | Nov. 20, 2009 |
| NASDAQ Official Close Price: | $ 4.75 |
| Date of NASDAQ Official Close Price: | Nov. 20, 2009 |
Intraday Chart |
| 5d | 1m | 6m | 12m | More Charting |
Have a Question About PTIE?
Ask your question about about Pain Therapeutics (PTIE) by typing it in the box below. You'll get direct responses from other members of the NASDAQ Answers community!
Hot Topics in NASDAQ Answers
The most popular questions & answers in the
NASDAQ Answers Community:
Company Description (as filed with the SEC)
We are a biopharmaceutical company that develops novel drugs. We have four drug candidates in clinical programs, including Remoxy, Oxytrex™, PTI-202 and a novel radio-labeled monoclonal antibody to treat metastatic melanoma. We are also working on a new treatment for patients with hemophilia. We were incorporated in Delaware in May 1998. We and King are engaged in a strategic alliance to develop and commercialize Remoxy and other abuse-resistant opioid painkillers. King made an upfront cash payment of $150.0 million to us at the closing of this strategic alliance in December 2005 and paid us $5.0 million as a milestone payment in connection with the acceptance by the FDA of an investigational new drug application, or IND, for PTI-202. We could also receive from King an additional $145.0 million in milestone payments in the course of clinical development of Remoxy, PTI-202 and other abuse-resistant opioid painkillers under the strategic alliance. ... More ...
Links to all Pain Therapeutics (PTIE) Pages
Stock Analysis
Fundamentals
Holdings/Ownership
Company News for PTIE |
||
|
Pain Therapeutics To Present At The Credit Suisse Healthcare Conference; Webcast At 4:30 PM ET - RTT News 11/11/2009 2:17PM |
||
|
Pain Therapeutics to Present at the Credit Suisse Healthcare Conference - GlobeNewswire 11/04/2009 9:00AM |
||
|
Pain Therapeutics Slips To Q3 Loss - Quick Facts - RTT News 10/29/2009 8:45AM |
||
|
Pain Therapeutics Reports Third Quarter 2009 Results - GlobeNewswire 10/29/2009 8:30AM |
||
|
5 Top Stocks at Half Price - The Motley Fool 09/28/2009 2:46PM |
||
|
Pain Therapeutics To Present At The UBS Global Life Sciences Conference; Webcast At 1:30 PM - RTT News 09/22/2009 12:09PM |
||
|
Pain Therapeutics to Present At UBS Global Life Sciences Conference - GlobeNewswire 09/16/2009 9:00AM |
